ライフサイエンスコーパス: interquartile

1 h CT HU (adjusted odds ratio [AOR] = 0.9989, interquartile odds ratio [IOR] = 0.4206) and BV/TV (AOR=

2 diture per beneficiary increased from $2932 (interquartile range $2232-$3870) to $4719 (interquartile

3 (interquartile range $2232-$3870) to $4719 (interquartile range $3124-$7209) per stay.

4 ant and had a median follow-up of 48 months [interquartile range (IQR) 36].

5 For an interquartile range (IQR) increase in PBB-153 (0.43 ng/m

6 The median interquartile range (IQR) time from reaction to peak MCT

7 but not in ventilated-paced subjects (0.84 [interquartile range (IQR), 0.78-0.89] vs. 1.10 [IQR, 1.0

8 0,000 firstborn children under age 2 months (interquartile range (IQR), 682-862) to 315 per 100,000 (

9 ntified 867 Local patients who traveled 2.7 [interquartile range (IQR): 1.6-4 miles] miles to centers

10 sidents were 46.3 A-weighted decibels (dBA) [interquartile range (IQR): 44.3-47.8 dBA] and 42.3 dBA (

11 median absolute prediction was 1.5 diopters (interquartile range 0.75-2 diopters).

12 t once during follow-up (over a median 18 y; interquartile range 16-19).

13 RBC units were transfused for a median of 2 (interquartile range 2-4) units transfused per patient.

14 al length of stay remained unchanged at 3.0 (interquartile range 2.0-5.0) days, but median Medicare i

15 The median age at surgery was 3.3 years (interquartile range 2.7-5 years), and the median follow-

16 47%) had CFLD at a median age of 36.6 years (interquartile range 26.5-43.2).

17 Median follow-up was 43 months (interquartile range 35-47).

18 gelatinase-associated lipocalin [14.7 mug/L (interquartile range 7.60-28.9) vs 18.4 mug/L (interquart

19 nterquartile range 7.60-28.9) vs 18.4 mug/L (interquartile range 8.30-21.2); Pnoninferiority = 0.0011

20 ) in those who progressed versus 2.76 hours (interquartile range = 1.60-4.82) in those who did not (p

21 median time to antimicrobial was 3.77 hours (interquartile range = 1.96-6.42) in those who progressed

22 US hospital referral regions (median = 33%, interquartile range = 17%-49%).

23 ive odds ratio, 1.15; 95% CI, 1.03-1.26; per interquartile range [1.7 mug/m(3)] increase in prenatal

24 included with a mean follow-up of 5.0 years (interquartile range [IQR] 1.6-7.33 years).

25 edian time to treatment decreased from 44 d (interquartile range [IQR] 20-69) in 2011 to 22 d (IQR 2-

26 The median survival time was 82 days (interquartile range [IQR] 22-638).

27 e transplanted at a median MELD score of 39 (interquartile range [IQR] 37-40) with 30-day posttranspl

28 ling (n = 246, median follow-up = 3.1 years, interquartile range [IQR] = 2.0-4.0).

29 Nm urethritis were a median age of 31 years (interquartile range [IQR] = 24-38) and had a median of 2

30 vels in the TDP-43 group (median = 7.4pg/ml; interquartile range [IQR] = 6.0, 12.3; n = 26) compared

31 niparib) and in nodes (median difference and interquartile range [IQR] before and after treatment: -2

32 Median (interquartile range [IQR]) Acute Physiology and Chronic

33 ents (59.4% men; 40.5% women) with a median (interquartile range [IQR]) age of 54 (45-63) years and 2

34 ters, 4644 (54.7%) were male and the median (interquartile range [IQR]) age was 69 (17-156) months.

35 The median (interquartile range [IQR]) Hospital Capability Index, re

36 Programs had a median (interquartile range [IQR]) number of 30 (20-48) categori

37 d" had higher median price per ounce ($0.79; interquartile range [IQR], $0.56-$1.27) than products wi

38 was lower with viral pathogens (0.09 ng/mL; interquartile range [IQR], <0.05-0.54 ng/mL) than atypic

39 n who saw the movie containing guns was 2.8 (interquartile range [IQR], 0.2-2.8) compared with 0.01 (

40 ac magnetic resonance imaging scan at day 1 (interquartile range [IQR], 1-1) and again at day 92 (IQR

41 dian age at cataract surgery was 2.2 months (interquartile range [IQR], 1.2, 3.5 months).

42 ow-up period (TNF-alpha: median, 1.92 pg/mL; interquartile range [IQR], 1.43-2.67 pg/mL vs median, 2.

43 an progression-free survival was 3.9 months (interquartile range [IQR], 1.5-5.9) with selumetinib + d

44 y from an ophthalmologist (median, 39 miles; interquartile range [IQR], 13-113 miles) compared with a

45 n, the median age at first FS was 21 months (interquartile range [IQR], 14-31 months).

46 higher median viral loads (3.9 log10 IU/mL; interquartile range [IQR], 2.6-6.0 log10 IU/mL) than con

47 tumor doubling time for controls was 5.5 d (interquartile range [IQR], 2.8-7.0), compared with 17.5

48 ntrols (median, 25.5 cell layers to surface; interquartile range [IQR], 21.4-28.8) vs patients with E

49 included (median CD4 count 53 cells/microL (interquartile range [IQR], 22-132); 16 (27%) died after

50 The median overall survival was 61.2 (interquartile range [IQR], 22.0-111.0), 70.4 (IQR, 26.7-

51 and 2011, with a median annual volume of 43 (interquartile range [IQR], 23-76) SAVR, 13 (IQR, 6-22) M

52 lood loss in the fibrinogen group was 50 mL (interquartile range [IQR], 29-100 mL) compared with 70 m

53 ent a median of 11 postmarket modifications (interquartile range [IQR], 3-24.8) across a median 10.0-

54 Median cough duration was 5 days (interquartile range [IQR], 3-8 days) in the prednisolone

55 Among 3886 women (median age, 38 years; interquartile range [IQR], 30-46 years) eligible for the

56 utflow tract dimension increased from 35 mm (interquartile range [IQR], 31 to 39) to 37 mm (IQR, 33 t

57 ed median time to evaluation from 70.0 days (interquartile range [IQR], 33.25-83.0 days) to 0.5 days

58 Median donor and recipient age was 52 years (interquartile range [IQR], 41-62 years) and 58 years (IQ

59 Patients had a median age of 52.3 years (interquartile range [IQR], 43.7-57.6 years) and a median

60 microscopy was positive for a median of 119 (interquartile range [IQR], 47-386) bacteria/microL sputu

61 Mean age was 54 (interquartile range [IQR], 47-64) years, and mean perito

62 were male and the median age was 67.8 years (interquartile range [IQR], 62.1-73.8 years).

63 he median baseline peak Vo2 was 1196 mL/min (interquartile range [IQR], 887-1448 mL/min) in the oral

64 uring a median follow-up time of 10.1 years (interquartile range [IQR], 9.1-11.5) progression of CAD

65 who underwent CPET at median age 12.6 years (interquartile range [IQR], 9.9-14.6 years).

66 an difference before and after treatment and interquartile range [IQR]: -17 g/mL. min, respectively [

67 coronary syndrome (median difference: 0.69; interquartile range [IQR]: 0.22 to 1.15; p = 0.008) and

68 ndurance training for a median of 15 h/week (interquartile range [IQR]: 10 to 20 h/week) for a median

69 At a median follow-up of 4.7 years (interquartile range [IQR]: 2.3 to 7.3 years), 98 patient

70 tion Effects on Quality of Life score of 80 (interquartile range [IQR]: 62.5 to 92.6) versus 82.4 (IQ

71 onsidering the magnitude of the uncertainty (interquartile range and the root-mean-squared error) of

72 thma (for cockroach allergen: odds ratio per interquartile range increase in concentration, 0.55; 95%

73 s ratio [aOR], 1.14; 95% CI, 1.02-1.28 per 1 interquartile range increase in NO2 [2.2 ppb]) and curre

74 ive odds ratio, 1.28; 95% CI, 1.15-1.41; per interquartile range increase in PM2.5).

75 interval (CI)] for incident diabetes per an interquartile range increase in SigmaAs was 1.57 (95% CI

76 x 10(5) to 9.10 x 10(5) particles/ml) for an interquartile range increment in annual residential blac

77 A-IR [e.g., -10.1% (95% CI: -17.3, -2.3) per interquartile range increment in PFOA].

78 as predictive of breast cancer risk overall (interquartile range odds ratio [IQ-OR], 1.37; 95% CI, 1.

79 ion test parameters compared with median and interquartile range of (19)F washout parameters.

80 roup and the higher-target group (19.4 days [interquartile range {IQR}, 0 to 24.2] and 19.4 days [IQR

81 arm relative to the DP arm (females: 0.05% [interquartile range {IQR}, 0.0-0.7%] of baseline; males:

82 DF) without a protease inhibitor (PI) (0.18 [interquartile range {IQR}, 0.08-0.30]; n = 372), LDV/SOF

83 tients identified (537 [46%] female; median [interquartile range {IQR}] age, 56 [44-66] years), 250 w

84 n in regions without (median FAcontra: 0.29 [interquartile range {IR}, 0.22-0.36] vs 0.46 [IR, 0.38-0

85 in and proteinemia were respectively median (interquartile range) 20.2 g/dL (17.9-22 g/dL) and 50 g/L

86 rvals between EMG- and motion onset, median (interquartile range) 96 (121) ms and 48 (72) ms, respect

87 ety-three women completed the study, median (interquartile range) age 43.0 (24.0-61.0) years for grou

88 The 717 residents had a median (interquartile range) age at enrollment of 2.6 (0.4-9.1)

89 Our 300-patient cohort had a median (interquartile range) age of 20 months (11-37 mo), and 44

90 including 769 females (55.9%) with a median (interquartile range) age of 37 (26-47) years.

91 We enrolled 821 patients with a median (interquartile range) age of 61 (51-71) years, Acute Phys

92 Their median (interquartile range) age was 32.5 (26-40) years; 380 (53

93 The median (interquartile range) age was 54 (42-65) years, and 2839

94 children; 1262 were male (53.6%) and median (interquartile range) age was 6 (1-13) years.

95 Median (interquartile range) age, body mass index, and body surf

96 atients were 68 +/- 12 years old (median +/- interquartile range) and had had autonomic failure for 5

97 RTRs with ID had median (interquartile range) cFGF23 concentrations higher than t

98 The median (interquartile range) follow-up time was 9.1 (5.1-12.6) y

99 e men and 3637 (53%) were women; median age (interquartile range) for control and SSI cases was 60 (4

100 ns compared to Group II: fibrinogen (median (interquartile range) Group I: 0.09 (0.00) mug/mL, Group

101 Baseline median (interquartile range) NT-proBNP levels were 4601 (2697-95

102 The median (interquartile range) number of inpatient admission hospi

103 ash presentation and continued for a median (interquartile range) of 14 (14-15) days, all patients su

104 e enrolled 1,040 patients who were a median (interquartile range) of 62 (53-72) years old and who had

105 The median (interquartile range) test-retest intraclass correlation

106 y (54.0% vs 19.4%; P < .001) and the median (interquartile range) time for this performance was earli

107 was on day 2 after injury (mg/dL; median and interquartile range): ASO 2.5mg/kg: 1.9 (1.3; 3.2), ASO

108 free flap breast reconstruction was $22677 (interquartile range, $14907-$33391).

109 nge, 5-22), and median total charge $70,722 (interquartile range, $30,591-$159,013).

110 s (interquartile range, 2-7 days) and $8302 (interquartile range, $5229-16 021), respectively.

111 and all items with consensus (median, >/=4; interquartile range, </=1) were ranked by importance in

112 , with a median increase in mPAP of 5 mm Hg (interquartile range, -1 to 11 mm Hg; P < .001).

113 Richmond Agitation Sedation Scale was -4.5 (interquartile range, -5 to -3.6) with sevoflurane delive

114 is, 16 (27%) died after a median of 12 days (interquartile range, 0-24 days); 29 (64%) of the 45 not

115 (9.4 [interquartile range, 0-60.9] versus 0 [interquartile range, 0-43.5]; P=0.02) and prevalence of

116 ) had a significantly higher CAC score (9.4 [interquartile range, 0-60.9] versus 0 [interquartile ran

117 ct prior treatment modalities (median, 0.12; interquartile range, 0.03-0.20; P = .007).

118 ir concentration was 0.10 parts per million (interquartile range, 0.07-0.15), 0.17 parts per million

119 nge, 0.14-0.27), and 0.15 parts per million (interquartile range, 0.07-0.19) at baseline, S1, and S2,

120 e range, 0.07-0.15), 0.17 parts per million (interquartile range, 0.14-0.27), and 0.15 parts per mill

121 intraclass correlation coefficient of 0.23 (interquartile range, 0.21-0.25), was also observed, impl

122 ian minimum alveolar concentration of 0.45% (interquartile range, 0.4-0.53) yielding a mean inspirato

123 After a median follow-up of 1.32 years (interquartile range, 0.57-2.34 years), there were 27 hip

124 serum creatinine, 0.87+/-0.20; median, 0.80; interquartile range, 0.70-1.01 mg/dL; glomerular filtrat

125 male (n = 51 [62%]), median age was 5 years (interquartile range, 1-12 years), one-third were Hispani

126 umber of prolonged disruptions were 3 hours (interquartile range, 1-4) and three (interquartile range

127 in 267 (17%) and lasted a median of 2 days (interquartile range, 1-5).

128 ocardiograms over a median follow-up of 2.0 (interquartile range, 1.0-3.0) years.

129 had shorter length of delirium/coma (1.5 d [interquartile range, 1.0-3.0] vs 3.0 d [interquartile ra

130 2.8 (standard deviation, 2.5) (median, 2.0; interquartile range, 1.0-4.0).

131 er a median follow-up duration of 2.8 years (interquartile range, 1.1-4.6 years).

132 uses during a median follow-up of 2.8 years (interquartile range, 1.3 to 5.1 years) from 1 year after

133 osylceramide slightly elevated (median, 4.9; interquartile range, 1.3-9.1 ng/mL).

134 % [interquartile range, 3.3%-17.8%] to 6.8% [interquartile range, 1.8%-12.9%], P=0.04).

135 6%]; and median diabetes duration, 19 years [interquartile range, 10-31 years]), 155 (98%) completed

136 and STEMI (median DTN time <60 minutes: 21% [interquartile range, 11-30]; median D2B time <90 minutes

137 males and 476 males; median age, 11.4 years [interquartile range, 11.1-11.8 years]), the combined rat

138 4+ count was 340 cells per cubic millimeter (interquartile range, 117 to 431).

139 nd 725 boys) with a median age of 27 months (interquartile range, 12-69 months).

140 ntile) had, on average, 27.8 times the odds (interquartile range, 12.7-60.6) of having delirium compa

141 erquartile range, 4-15 days) versus 24 days (interquartile range, 14-38 days) in patients without ver

142 59) and were followed a median of 27 months (interquartile range, 14-47).

143 nd Chronic Health Evaluation-II score, 19.0 [interquartile range, 14.0-24.0]) were screened for poste

144 nterquartile range,19.88 to 112.39] v 35.78 [interquartile range, 14.09 to 99.22] months; P < .001).

145 The median follow-up was 21.5 months (interquartile range, 14.3-31.0).

146 ial pressure falling by a median of 22 mmHg (interquartile range, 14.3-31.9 mmHg) and dropping below

147 7 males and 7 females; median age, 16 years [interquartile range, 15.0-22.5 years]) randomized, 13 co

148 Thus, only 34% (interquartile range, 15.6%-75.7%) of the estimated diure

149 ab and followed for a median of 16.5 months (interquartile range, 15.8 to 16.7 months).

150 (median age at initial diagnosis, 19 years; interquartile range, 16-22 years; 1196 male [16.5%]; 505

151 Thirty-day RSRRs varied from 10.0% to 27.3% (interquartile range, 16.6% to 18.8%).

152 restricted visitation model to 245 minutes (interquartile range, 175.0-272.0) in extended visitation

153 erquartile range, 24-44] for 1970s vs 26 Gy [interquartile range, 18-45] for 1990s).

154 ion was followed for a median of 24.7 years (interquartile range, 18.9-32.4 years) with 1% lost.

155 onset to arterial puncture was 227 minutes (interquartile range, 180-280 minutes).

156 The median age was 31 years (interquartile range, 19-44 years).

157 did not achieve complete dosing was 34.2 Gy (interquartile range, 19.8-40.0 Gy).

158 Median time to reintubation was 15 hours (interquartile range, 2-45 hr).

159 included in the study (median age, 3 months; interquartile range, 2-5 months; 468 [60.2%] male), 385

160 hours (interquartile range, 1-4) and three (interquartile range, 2-5), respectively.

161 e of the 1005 enrolled infants was 3 months (interquartile range, 2-6 months).

162 f stay and cost of readmissions were 4 days (interquartile range, 2-7 days) and $8302 (interquartile

163 s +/- 2.28 into the shift (median, 10 hours; interquartile range, 2.0 hours).

164 12 years and median follow-up was 2.3 years (interquartile range, 2.0-2.9).

165 ge, 2.5-5.0]; p = 0.03) and ICU stay (3.0 d [interquartile range, 2.0-4.0] vs 4.0 d [interquartile ra

166 to June 7, 2016, for a median of 3.1 years (interquartile range, 2.0-4.2 years; maximum follow-up, 1

167 0 d [interquartile range, 2.0-4.0] vs 4.0 d [interquartile range, 2.0-6.0]; p = 0.04).

168 the median comorbid criterion count was 6.2 (interquartile range, 2.3-10.9).

169 5 d [interquartile range, 1.0-3.0] vs 3.0 d [interquartile range, 2.5-5.0]; p = 0.03) and ICU stay (3

170 Median post-LT follow-up was 7.6 years (interquartile range, 2.8-14.4).

171 s resuppressed after a median of 8.0 months (interquartile range, 2.8-16.8 months) in this setting wh

172 fter a median follow-up period of 26 months (interquartile range, 20-30 mo), no patients had a seriou

173 oup) at a median corrected age of 22 months (interquartile range, 21-23 months).

174 values less than 30 mg/dL (median, 25 mg/dL; interquartile range, 21-27 mg/dL) at 1 month were more l

175 ts with stable asthma (median age, 23 years [interquartile range, 21-27 years]; 60% female) and 47 he

176 After a mean follow-up of 56 months +/- 41 (interquartile range, 22-92), 22 patients (42%) experienc

177 ter wait times to transplantation, 485 days (interquartile range, 228-783) versus 969 days (interquar

178 overall cohort, the median age was 29 years (interquartile range, 24-33 years).

179 s 33% for 1990s), as did median dose (30 Gy [interquartile range, 24-44] for 1970s vs 26 Gy [interqua

180 ely high intake of food folate (median, 308; interquartile range, 241-366 mug/d) and nearly all took

181 atients were included (median age, 33 years; interquartile range, 25-41 years; 58% male; 90% New York

182 eline circulating PCSK9 level was 323 ng/mL (interquartile range, 258-406 ng/mL).

183 he ICU varied across hospitals (median, 38%; interquartile range, 26%-54%), but no significant differ

184 s who were randomized (median age, 34 years [interquartile range, 26.0-45.5 year]; 75.2% women; 100%

185 ICU admission occurred at a median of 146 (interquartile range, 27-321) days after allogeneic hemat

186 Median baseline HCV RNA was 2 280 000 IU/mL (interquartile range, 272 000-4 230 000).

187 47 healthy volunteers (median age, 38 years [interquartile range, 29-47 years]; 64% female) were recr

188 Median DFS was 71.4 months (interquartile range, 3 months to not reached) for girent

189 2), and the median CHA2DS2-VASc score was 4 (interquartile range, 3-5).

190 boys [67%]) with a median age of 5.0 months (interquartile range, 3.0-8.0 months) were randomized; 11

191 psoriasis, with a median PASI score of 5.2 (interquartile range, 3.0-8.9).

192 girls [29.9%]; median age at AIS, 7.7 years [interquartile range, 3.1-13.6 years]).

193 nts were followed for a median of 5.9 years (interquartile range, 3.1-8.3 years).

194 n serum albumin level decreased to 3.7 g/dL (interquartile range, 3.2-4.1 g/dL) (P < .001), and the n

195 ring a median follow-up period of 4.8 years (interquartile range, 3.2-8.3 years).

196 hole kidney with R2*>30/s) decreased (12.1% [interquartile range, 3.3%-17.8%] to 6.8% [interquartile

197 primary end point during a follow-up of 6.7 (interquartile range, 3.3-10.0) years.

198 ive care consultation to death was 10 hours (interquartile range, 3.36-66 hours).

199 use per hospital was 6.8% (range, 0%-34.7%; interquartile range, 3.4%-12.1%), with hospitals in the

200 During a median follow-up of 5.0 years (interquartile range, 3.5-6.0 years), 38 (15%) patients d

201 time to first follow-up RHC was 4.6 months (interquartile range, 3.7-7.8 months).

202 the median serum albumin level was 4.2 g/dL (interquartile range, 3.8-4.5 g/dL), with hypoalbuminemia

203 tion, the median CTG expansion size was 530 (interquartile range, 300-830).

204 Median age of the study cohort was 46 (interquartile range, 32-58).

205 ) (77% female; median age at enrollment, 48 [interquartile range, 36-56] years).

206 At baseline, the median age was 43 (interquartile range, 39-49), 85% were men, 74% were on a

207 patients' median age of onset was 52 years (interquartile range, 39-59) and were followed a median o

208 Median intensive care unit stay was 7 days (interquartile range, 4-15 days) versus 24 days (interqua

209 an interval from the Norwood to S2P was 5.1 (interquartile range, 4.1-6.0) months.

210 (PSA) of 6.4 ng/mL (range, 2.2-158.4 ng/mL; interquartile range, 4.2-10.2 ng/mL) were finally eligib

211 median age of pediatric cases was 10 years (interquartile range, 4.7-14.5 years).

212 g/d of supplemental folic acid (median, 500; interquartile range, 400-600 mug/d).

213 Among 571 patients (median age, 49 years [interquartile range, 43-55 years]; 430 men and 141 women

214 median age of the participants was 50 years (interquartile range, 43-60 years), and 1422 (48.6%) were

215 in the study, with a median age of 50 years (interquartile range, 44-57 years).

216 terquartile range, 228-783) versus 969 days (interquartile range, 452-2008; P = 0.02).

217 HANES, the median weighted age was 53 years (interquartile range, 46-61), and 53% (95% CI, 52%-55%) w

218 and 206 women [44.9%]; median age, 62 years [interquartile range, 46-75 years]) were admitted during

219 ball players (median age at death, 66 years [interquartile range, 47-76 years]), CTE was neuropatholo

220 % men and 53.2% women; median age, 59 years [interquartile range, 49-69 years]) were identified.

221 The median age was 63 years (interquartile range, 49-74), and 6,224 (61%) were male.

222 II DSA in the peak or day 0 serum was 9421 (interquartile range, 4959-12 610).

223 s 33.2%, with median length of stay 11 days (interquartile range, 5-22), and median total charge $70,

224 he median follow-up (n = 405) was 9.1 years (interquartile range, 5.0-15.2 years), with a median meno

225 The median follow-up was 39.0 months (interquartile range, 5.1-72.9 months).

226 th PCa with a median follow-up of 8.3 years (interquartile range, 5.2 to 11.5 years) until death from

227 Of the 98999 women (median age, 60 years [interquartile range, 50-71 years]) in the study, 21123 (

228 1040 patients, the median age was 58 years (interquartile range, 50.5-66 years), 65.3% were male, an

229 3.9%) were male and median age was 58 years (interquartile range, 51-68 years).

230 players (87%; median age at death, 67 years [interquartile range, 52-77 years]; mean years of footbal

231 , 303 (89%) consented (median age, 62 years [interquartile range, 53-71]; 57% men; 32% African Americ

232 xed adult ICU patients (median age, 66.0 yr [interquartile range, 54.0-74.0]; Acute Physiology and Ch

233 % men and 49.2% women; median age, 65 years [interquartile range, 55-73 years]) and 52284 patients un

234 , 60-75 years) in the MAC group vs 67 years (interquartile range, 55.5-78.5 years) in the GA group (P

235 3% male (n = 79) and had a median age of 67 (interquartile range, 58-74) years.

236 The median age was 69 years (interquartile range, 58-79 years), 45073 patients (42%)

237 ale and the median patient age was 67 years (interquartile range, 59-74 years).

238 for 22 patients (31.4%) (mean age, 76 years [interquartile range, 59-86 years]; 13 of the 22 patients

239 s received the mHELP for a median of 7 days (interquartile range, 6-10 days) and had a shorter median

240 low-up after radiation treatment of 10.5 mo (interquartile range, 6-14 mo).

241 At study entry, median age was 11 months (interquartile range, 6-16 months); 17% were sensitized,

242 iagnosis of dementia (median, 11.5 microg/L; interquartile range, 6.5-14.9 microg/L) and controls (me

243 At a median follow-up of 9.3 years (interquartile range, 6.93-10.34 years), the 10-year over

244 Median age was 69 years (interquartile range, 60-75 years) in the MAC group vs 67

245 0% male (n = 48) and had a median age of 68 (interquartile range, 60-75) years.

246 patients, 94 (96%) (median age, 68.8 years [interquartile range, 61.2-75.3 years]; 45% women) were i

247 e, 11-30]; median D2B time <90 minutes: 68% [interquartile range, 62-79]; rho=-0.14; P=0.36).

248 for 48 patients (68.6%) (mean age, 77 years [interquartile range, 65-84 years]; 22 of the 48 patients

249 The median age was 75 years (interquartile range, 67-82), and the median CHA2DS2-VASc

250 rom orthopedic implant placement, 11 months [interquartile range, 7-16]), 470 patients completed the

251 crog/L) and controls (median, 12.2 microg/L; interquartile range, 7.3-16.0 microg/L; P < .001).

252 Median age was 82 years (interquartile range, 70-88).

253 and 733653 controls (median age, 80.3 years; interquartile range, 74.9-84.6 years; 44 760 female [60.

254 median number of patients per study was 185 (interquartile range, 75-305), and the median follow-up d

255 6 women and 11971 men; median age, 84 years [interquartile range, 78-88 years]), off-label TAVR was u

256 luded in the analysis (median age, 10 years; interquartile range, 8-13 years; 1467 [60.4%] male).

257 (median age at initial diagnosis, 11 years; interquartile range, 8-15 years; 2972 male [54.5%]; 4505

258 s had a median of 15 organ dysfunction days (interquartile range, 8-20).

259 Median follow-up was 20.9 months (interquartile range, 8.7-40.4 months).

260 ients included in the trial (median age, 85 [interquartile range, 81-89] years; 1361 [45%] men).

261 ular filtration rate, 102+/-23; median, 106; interquartile range, 84-113 mL/min) were discreet.

262 the median follow-up duration was 180 days (interquartile range, 84-270 days).

263 enrolled in the preapproval studies was 132 (interquartile range, 89-224).

264 study included 9410 women (median age, 27.0 [interquartile range, 9.0] years; 60.7% non-Hispanic whit

265 At 10.8 years (interquartile range, 9.6-12.3), 82 (9%) died (0.4% in-ho

266 ration of visits increased from 133 minutes (interquartile range, 97.7-162.0) in restricted visitatio

267 tly longer for AC versus observation (47.41 [interquartile range,19.88 to 112.39] v 35.78 [interquart

268 examination was considered unreliable if LSM interquartile range/median was >30%.

269 he reported median effect size was D = 0.93 (interquartile range: 0.64-1.46) for nominally statistica

270 at referral was similar for men (22.5 years; interquartile range: 19.5-26.7) and women (23.4 years; i

271 ile range: 19.5-26.7) and women (23.4 years; interquartile range: 19.5-29.1); incidence rates were hi

272 low-up period of 14 years (median 3.8 years [interquartile range: 2.0 to 6.1 years] for +MWF and 4.6

273 e: 2.0 to 6.1 years] for +MWF and 4.6 years [interquartile range: 2.4 to 8.3 years] for -MWF).

274 r disease risk score of the cohort was 4.8% (interquartile range: 2.8% to 8.0%).

275 Median age was 41 years (interquartile range: 27 to 53 years) with similar preval

276 sions: mean 20.3 +/- 32.7 units, median = 8 (interquartile range: 3, 24) versus mean 31.8 +/- 44.3 un

277 Median follow-up was 173 days (interquartile range: 54 to 342 days).

278 ersus mean 31.8 +/- 44.3 units, median = 16 (interquartile range: 7, 40) in the liberal group (P < 0.

279 After a median follow-up of 12 months (interquartile range: 7-16 months), median event-free sur

280 (40%) during a median follow-up of 325 days (interquartile range: 85 to 401).

281 measured for 196 d (mean=0.32 nmol/min/m(3), interquartile range=0.21).

282 -type natriuretic peptide increased (median [interquartile range] 13 [7 to 25] pg/mol vs. 18 [9 to 36

283 mbda compared with healthy controls (median [interquartile range] 4.1% [2.4-11.0] vs 1.3% [1.2-2.9],

284 erquartile range] age 63 [57-67] yr, median [interquartile range] Acute Physiology and Chronic Health

285 stay in 30 critically ill patients (median [interquartile range] age 63 [57-67] yr, median [interqua

286 boys [52.0%] and 657 girls [48.0%]; median [interquartile range] age, 12.9 [11.2-15.3]), of whom 684

287 A total of 864 patients (66% male; median [interquartile range] age, 58 [51-65] years) were randomi

288 5 men [76.2%] and 523 women [23.8%]; median [interquartile range] age, 62 [52-72] years), complete 1-

289 A total of 12473 patients (median [interquartile range] age, 64 [57-70] years) were identif

290 ed in-hospital delirium assessments (median [interquartile range] age, 74.0 [71.0-78.0] years; 51.3%

291 were older than immigrant decedents (median [interquartile range] age, 75 [58-84] vs 80 [68-87] years

292 A continuous trend for a decrease in median [interquartile range] Kerma area product was observed, fr

293 ilonacept also reduced hsCRP levels (median [interquartile range]) (baseline: 4.60 [1.90-8.22] mg/L,

294 anesthetic dose of 1.20 (1.13-1.30) (median [interquartile range])-fold median effective dose equival

295 ation compared with spherical cuffs (median [interquartile range], 77.9% [0-99.8] vs. 0% [0-0.5]; p =

296 d sudden infant death syndrome mortality per-interquartile-range increase (1.3 mug/m3) in lifetime PM

297 ating equations estimated relative risks per interquartile-range increment for pollutants and high ex

298 For an interquartile-range increment, GH risk was significantly

299 ory variability for all tested viruses, with interquartile ranges as high as 1.46 log10 copies/ml and

300 Interquartile ranges for UAS7 and UAS7TD values for mild